Showing results (201-210 of 216) with videos related to
Sort By:
Pageof 22
BMJ Open|November 16, 2020
Embryo incubation by time-lapse systems versus conventional incubators in Chinese women with diminished ovarian reserve undergoing IVF/ICSI: a study protocol for a randomised controlled trialMiaoxin Chen, Yuanyuan Wu, Xin Huang, et al.Molecular Therapy : the Journal of the American Society of Gene Therapy|December 16, 2021
FTO promotes multiple myeloma progression by posttranscriptional activation of HSF1 in an m<sup>6</sup>A-YTHDF2-dependent mannerAoshuang Xu, Jiasi Zhang, Liping Zuo, et al.Annals of Hematology|November 12, 2025
Development of an artificial intelligence-based early diagnostic system for light-chain amyloidosisWei Yan, Jian Chen, Tao He, et al.Biochemical Pharmacology|April 14, 2025
LncRNA HCG11 regulates selinexor sensitivity in multiple myelomaYue Zhang, Xin Wang, Hongmei Luo, et al.Cancer Letters|November 20, 2023
RNA-binding protein hnRNPU regulates multiple myeloma resistance to selinexorXin Wang, Juan Xu, Qun Li, et al.Autoimmunity Reviews|June 1, 2017
Comparative clinical characteristics and natural history of three variants of sclerosing cholangitis: IgG4-related SC, PSC/AIH and PSC aloneMin Lian, Bo Li, Xiao Xiao, et al.Gut|June 16, 2019
Alterations of gut microbiome in autoimmune hepatitisYiran Wei, Yanmei Li, Li Yan, et al.ACS Medicinal Chemistry Letters|September 27, 2017
Design, Synthesis, and Evaluation of Tetrahydropyrrolo[1,2-<i>c</i>]pyrimidines as Capsid Assembly Inhibitors for HBV TreatmentXiaolin Li, Kai Zhou, Haiying He, et al.Journal of Hematology & Oncology|October 10, 2021
A bispecific CAR-T cell therapy targeting BCMA and CD38 in relapsed or refractory multiple myelomaHeng Mei, Chenggong Li, Huiwen Jiang, et al.Leukemia|May 19, 2021
JunB is a key regulator of multiple myeloma bone marrow angiogenesisFengjuan Fan, Stefano Malvestiti, Sonia Vallet, et al.Pageof 22